Show Notes
What’s your biggest struggle right now?
In this episode of Life During and After GLP-1, I’m opening up the conversation and asking you to reflect on where you currently are in the process.
Because when you really step back and think about it, GLP-1 medications can impact so much more than just the scale.
Your body changes. Your routines change. Your relationship with food changes. Your identity can change. Even the way you emotionally process life can start to shift.
That is a lot for one person to navigate all at once.
In this episode, I talk about why these conversations around body image, body noise, identity, emotional eating, coping mechanisms, and long-term lifestyle change matter so much. I also share why I shifted this podcast into a daily format and why I believe these conversations need more depth, context, and honesty than what’s often presented in the fitness space.
This episode is shorter and more reflective, but the message is important.
I want to hear from you.
What are you struggling with right now? What is going well? What changes are you noticing physically, mentally, or emotionally?
Because sustainable change is not just about actions. It is also about understanding yourself throughout the process.
Your Level Fitness Links:
Build Your Forever Active Lifestyle: https://yourlevelfitness.com
Join The Community: https://yourlevelfitness.com/community
Connect With Yourself On A Deeper Level Through The Journal Prompts: https://yourlevelfitness.com/email
More from The Life During And After GLP-1 Podcast
Rachel has lost 100 pounds more than once.
What happens when a GLP-1 gives you relief from Food Noise, but part of you is already worried about what happens if that relief changes?
GLP-1 conversations are often presented as simple success stories.
In this episode of Life During and After GLP-1, I’m joined by Jennifer to talk about her personal experience with GLP-1 medication, from the decision to start through weight loss, side effects, rebuilding muscle, and eventually reaching the question of what comes next.
GLP-1 medications are becoming more mainstream, and the conversation around them is becoming much more nuanced.